REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 82 filers reported holding REVANCE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $206,327 | -41.0% | 11,177 | -48.3% | 0.01% | -84.4% |
| Q3 2016 | $350,000 | +14.4% | 21,611 | -4.0% | 0.03% | -13.5% |
| Q2 2016 | $306,000 | +8.1% | 22,515 | +39.0% | 0.04% | -2.6% |
| Q1 2016 | $283,000 | -96.4% | 16,195 | -93.0% | 0.04% | -95.0% |
| Q4 2015 | $7,864,000 | +17.4% | 230,211 | +2.3% | 0.76% | +30.4% |
| Q3 2015 | $6,696,000 | -16.2% | 225,000 | -10.0% | 0.58% | +3.0% |
| Q2 2015 | $7,995,000 | +38.4% | 250,000 | -10.3% | 0.57% | +23.2% |
| Q1 2015 | $5,775,000 | +36.0% | 278,568 | +11.2% | 0.46% | +57.9% |
| Q4 2014 | $4,245,000 | +9.9% | 250,605 | +25.4% | 0.29% | +9.4% |
| Q3 2014 | $3,864,000 | -24.2% | 199,895 | +33.3% | 0.27% | -0.4% |
| Q2 2014 | $5,100,000 | +61.9% | 150,000 | +50.0% | 0.27% | +119.7% |
| Q1 2014 | $3,150,000 | – | 100,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |